Jay Eastman

---

Jay Eastman is the Co-founder and Principal of EG Capital Group and a longtime philanthropic leader with deep experience in private equity and strategic investing. He currently leads EG Capital Group, a New York City-based family office/private equity firm focused on buyouts and growth capital for small and mid-sized consumer and retail companies in North America. Earlier in his career, he worked on the mergers and acquisitions teams at JP Morgan in New York and London and in real estate finance at Heitman/JMB in Chicago. Jay and his wife Katama chair the Advisory Board at the Naomi Berrie Diabetes Center at Columbia University Medical Center and he has been actively involved in life sciences investing through Dana-Farber Cancer Institute, including board roles with OncoPep and C4 Therapeutics. He and Katama have been involved with Breakthrough T1D (formerly JDRF) since 2004, when their daughter Merrill was diagnosed with type 1 diabetes at 15 months old. Jay holds an M.B.A. from Columbia University and a B.S. from Lake Forest College. He chairs the T1D Fund’s Board of Directors and is a member of the Investment, Nominating & Governance, Capital, and Compensation Committees.